Harvard Bioscience (HBIO) Misses Q4 EPS by 10c
Tweet
Share
E-mailGet Alerts HBIO Hot Sheet
Price: $7.96 -0.25%
Revenue Growth %: +6.1%
Financial Fact:
Income before income taxes: -880K
Today's EPS Names:
OCCI, ALZN, ASPU, More
Revenue Growth %: +6.1%
Financial Fact:
Income before income taxes: -880K
Today's EPS Names:
OCCI, ALZN, ASPU, More
Join SI Premium – FREE
Harvard Bioscience (NASDAQ: HBIO) reported Q4 EPS of ($0.06), $0.10 worse than the analyst estimate of $0.04. Revenue for the quarter came in at $23.7 million versus the consensus estimate of $23.1 million.
For earnings history and earnings-related data on Harvard Bioscience (HBIO) click here.
Serious News for Serious Traders! Try StreetInsider.com Premium Free!
You May Also Be Interested In
- Boeing wins $20B U.S. Navy contract for sixth-generation fighter jet
- Raytheon wins $314M in U.S. Navy and Army defense contracts
- Marvel Biosciences closes private placement raising $1.6 million
Create E-mail Alert Related Categories
EarningsRelated Entities
Earnings, Maynard Um, Mark Zuckerberg, ARKSign up for StreetInsider Free!
Receive full access to all new and archived articles, unlimited portfolio tracking, e-mail alerts, custom newswires and RSS feeds - and more!
